Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-69691-8
Abstract: Acute myeloid leukemia (AML) is a very heterogeneous and highly malignant blood cancer. Mutations of the DNA methyltransferase DNMT3A are among the most frequent recurrent genetic lesions in AML. The majority of DNMT3A-mutant AML patients… read more here.
Keywords: survival differences; aml patients; myeloid leukemia; dnmt3a mutant ... See more keywords